Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / HEALTHCARE BUL
-
Number of holders
-
18
-
Total shares
-
75.6K
-
Shares change
-
+51K
-
Total reported value, excl. options
-
$6.38M
-
Value change
-
+$4.3M
-
Put/Call ratio
-
0.57
-
Number of buys
-
8
-
Number of sells
-
-5
-
Price
-
$84.44
Significant Holders of DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) as of Q3 2022
21 filings reported holding CURE - DIREXION SHS ETF TR - HEALTHCARE BUL as of Q3 2022.
DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 75.6K shares
.
Largest 10 shareholders include HRT FINANCIAL LP (37.9K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (14.6K shares), Tower Research Capital LLC (TRC) (5.51K shares), Traynor Capital Management, Inc. (5.4K shares), Virtu Financial LLC (3.38K shares), Qube Research & Technologies Ltd (3.01K shares), Capital Investment Advisors, LLC (2.65K shares), Quantbot Technologies LP (681 shares), ADVISOR GROUP HOLDINGS, INC. (500 shares), and Kelly Financial Services LLC (387 shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.